Presentation Preview
Central Nervous System (CNS) disorders represent some of the most heterogeneous indications with different diseases manifesting similar symptoms and different patients within the same disorder experiencing widely varied symptomology. In addition, CNS disorders often cause significant impairment in the populations impacted. As such, clinical trial measurement in CNS trials must be highly sensitive, with precise scientific, operational, and technological considerations to support quality data collection and processing for informed decision making on the impacts of novel therapeutic compounds.
In particular, cognitive assessment in CNS trials often requires advanced eCOA solutions, seasoned clinical raters, specialized rater training, and stringent quality control strategies to ensure accurate data collection from highly nuanced scales. These requirements are managed across disparate systems, which can pose risks to data accuracy and operational efficiency.
Watch this webinar recording for a deep dive into how an integrated eCOA and rater training approach can transform your CNS trials. The speakers explore how flexible, customized eCOA configurations can streamline even the most complex workflows, and how integrating these solutions with Learning Management Systems (LMS) and central review platforms can enhance endpoint data quality and create efficiencies in trial operations.
Hear from Paul O’Donohoe, Senior Director, eCOA Product & Science from Medidata and Dr. Svenja Wacker, Science Director at Cogstate, as they share innovative strategies that sets the stage for CNS trial success.
Speakers
Svenja Wacker, PhD,
Science Director, Cogstate
Paul O’Donohoe,
eCOA Product & Scienc, Medidata
ACCESS RECORDING
